Screener / SEC EDGAR /CIK 0001711279 /10-K filed Feb 17, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Krystal Biotech, Inc. KRYS

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 19 Form 144 notices for $94.6M

10-Q, 10-K and Form 144
Plans running now 5 Laurent Goux, Kathryn Romano, Krish Krishnan, Suma Krishnan, John Thomas
Plans adopted 13 reported since May 8, 2023 Form 144 notices 19 $94.6M the sellers expected to sell

What KRYS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 29, 2023 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Laurent Goux
Executive Vice President, Head of International
Adopted 10b5-1 plan Sep 10, 2026 10-Q Nov 2, 2026
What the company wrote
On September 10, 2026, Laurent Goux, our Executive Vice President, Head of International, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 3,045 shares of our common stock to be acquired upon the exercise of vested stock options, subject to certain conditions. The trading arrangement will terminate on September 10, 2027, subject to early termination in accordance with its terms, including upon the completion of the sale of all of the shares of our common stock subject to the trading arrangement.
Kathryn Romano
Executive Vice President & Chief Accounting Officer
Adopted 10b5-1 plan Aug 31, 2026 10-Q Nov 2, 2026
What the company wrote
On August 31, 2026, Kathryn Romano, our Executive Vice President & Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 11,527 shares of our common stock (including up to 10,927 shares to be acquired upon the exercise of vested stock options), the exercise of vested stock options for up to 1,573 shares of our common stock to be held by Ms. Romano, and a charitable gift of up to 1,163 shares of our common stock, in each case subject to certain conditions. The trading arrangement will terminate on December 31, 2027, subject to early termination in accordance with its terms, including upon the completion of all transactions contemplated by the trading arrangement.
Daniel Janney
directors
Ended 10b5-1 plan Mar 9, 2026 10-Q May 4, 2026
What the company wrote
On March 9, 2026, Daniel Janney, one of our directors, terminated a Rule 10b5-1 trading arrangement that was originally adopted on November 25, 2025. The Rule 10b5-1 trading arrangement was terminated during the Company’s unrestricted trading window and at a time when Mr. Janney was not in possession of material, non-public information about the Company. 71,964 shares of our common stock were sold under the Rule 10b5-1 trading arrangement prior to termination of the arrangement.
Daniel Janney
Board of Directors
Adopted 10b5-1 plan Nov 25, 2025 10-K Feb 17, 2026
What the company wrote
On November 25, 2025, Daniel Janney, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 90,000 shares of the Company’s common stock, a portion of which will be issued upon exercise of stock options that if not exercised will expire in 2026. The Rule 10b5-1 trading arrangement will continue until November 5, 2026, subject to early termination in accordance with the terms of the Rule 10b5-1 trading arrangement, including upon completion of the sale of all of the shares of the Company’s common stock subject to the Rule 10b5-1 trading arrangement.
Kathryn Romano
Chief Accounting Officer
Adopted 10b5-1 plan Nov 6, 2025 10-K Feb 17, 2026
What the company wrote
On November 6, 2025, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 20,000 shares of the Company’s common stock and a gift of up to 750 shares of the Company’s common stock. The Rule 10b5-1 trading arrangement will continue until August 31, 2026, subject to early termination in accordance with the terms of the Rule 10b5-1 trading arrangement, including upon completion of the sale of all of the shares of the Company’s common stock subject to the Rule 10b5-1 trading arrangement.
Krish Krishnan
Chief Executive Officer and Chairman of our Board of Directors
Adopted 10b5-1 plan Sep 4, 2025 10-Q Nov 3, 2025
What the company wrote
On September 4, 2025, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the “Trading Plan”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock, subject to certain conditions. The end date of the Trading Plan is December 4, 2026, subject to early termination in accordance with the terms of the Trading Plan, including upon completion of the sale of all of the shares of our Common Stock subject to the Trading Plan.
Suma Krishnan
President and a member of our Board of Directors
Adopted 10b5-1 plan Sep 4, 2025 10-Q Nov 3, 2025
What the company wrote
On September 4, 2025, Suma Krishnan, our President and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the “Trading Arrangement”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock, subject to certain conditions. The end date of the Trading Arrangement is December 4, 2026, subject to early termination in accordance with the terms of the Trading Arrangement, including upon completion of the sale of all of the shares of our Common Stock subject to the Trading Arrangement.
Kathryn Romano
Chief Accounting Officer
Adopted 10b5-1 plan Nov 18, 2024 10-K Feb 19, 2025
What the company wrote
On November 18, 2024, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for (1) the exercise of 5,000 stock options and sale of the associated shares of common stock issued to Ms. Romano until the earlier of execution of all trades or August 20, 2025, and (2) the sale on February 26, 2025 of up to 750 shares of common stock issued to Ms. Romano pursuant to the vesting of a RSA award on February 26, 2025.
Krish Krishnan
Chief Executive Officer and Chairman of our Board of Directors
Adopted 10b5-1 plan Jun 14, 2024 10-Q Aug 5, 2024
What the company wrote
On June 14, 2024, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 13, 2025.
Suma Krishnan
President, R&D and a member of our Board of Directors
Adopted 10b5-1 plan Jun 14, 2024 10-Q Aug 5, 2024
What the company wrote
On June 14, 2024, Suma Krishnan, our President, R&D and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 13, 2025.
Kathryn Romano
Chief Accounting Officer
Adopted 10b5-1 plan Aug 29, 2023 10-Q Nov 6, 2023
What the company wrote
On August 29, 2023, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 25,000 shares of our Common Stock until June 28, 2024.
Krish Krishnan
Chief Executive Officer and Chairman of our Board of Directors
Adopted 10b5-1 plan Jun 12, 2023 10-Q Aug 7, 2023
What the company wrote
On June 12, 2023, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors,adopted a Rule 10b5 - 1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5 - 1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 11, 2024.
Suma Krishnan
President, R&D and a member of our Board of Directors
Adopted plan Jun 12, 2023 10-Q Aug 7, 2023
What the company wrote
On June 12, 2023, Suma Krishnan, our President, R&D and a member of our Board of Directors, adopted a Rule 10b5 - 1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5 - 1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 11, 2024.
John Thomas
Executive Vice President, General Counsel, and Corporate Secretary
Adopted 10b5-1 plan – 10-Q May 4, 2026
What the company wrote
On February 3, 2026, John Thomas, our Executive Vice President, General Counsel, and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement (the “Trading Plan”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 1,903 shares of our common stock, subject to certain conditions. The end date of the Trading Plan is December 31, 2026, subject to early termination in accordance with the terms of the Trading Plan, including upon completion of the sale of all of the shares of our common stock subject to the Trading Plan.
Show the other 6 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Sep 4, 2026 SUMA KRISHNAN
Director, Officer, 10% Stockholder
25,000 $9.3M
Sep 4, 2026 KRISH KRISHNAN
Director, Officer, 10% Stockholder
25,000 $9.3M
Aug 14, 2026 Dino A. Rossi
Director
25,000 $8.3M
Jun 25, 2026 Thomas John Charles
Officer
1,000 $347K
Jun 4, 2026 SUMA KRISHNAN
Director, Officer, 10% Stockholder
25,000 $7.5M
Jun 4, 2026 KRISH KRISHNAN
Director, Officer, 10% Stockholder
25,000 $7.5M
May 26, 2026 Thomas John Charles
Officer
642 $194K
Mar 4, 2026 SUMA KRISHNAN
Director, Officer, 10% Stockholder
25,000 $6.6M
Mar 4, 2026 KRISH KRISHNAN
Director, Officer, 10% Stockholder
25,000 $6.6M
Mar 2, 2026 ROMANO KATHRYN
Officer
750 $201K
Feb 27, 2026 Daniel S Janney
Director
11,803 $3.3M
Feb 26, 2026 Daniel S Janney
Director
7,741 $2.1M
Feb 25, 2026 Daniel S Janney
Director
700 $192K
Feb 24, 2026 JANNEY DANIEL
Director
37,895 $10.1M
Feb 24, 2026 Daniel S Janney
Director
13,825 $3.7M
Feb 19, 2026 ROSSI DINO A
Director
18,950 $5.0M
Feb 9, 2026 ROMANO KATHRYN
Officer
12,500 $3.5M
Dec 4, 2025 KRISH KRISHNAN
Director, Officer, 10% Stockholder
25,000 $5.4M
Dec 4, 2025 SUMA KRISHNAN
Director, Officer, 10% Stockholder
25,000 $5.4M
Show the other 11 notices

From the Form 144 XML filed with the SEC, since Dec 4, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KRYS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.